Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Lenalidomide × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 138 Lymphoma, Follicular 39 Lymphoma, Large B-Cell, Diffuse 35 Lymphoma, B-Cell, Marginal Zone 24 Lymphoma, Non-Hodgkin 16 Lymphoma 16 Lymphoma, Mantle-Cell 15 Recurrence 14 Neoplasms, Plasma Cell 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Neoplasms 9 Lymphoma, B-Cell 9 Smoldering Multiple Myeloma 8 Burkitt Lymphoma 5 Neoplasm, Residual 4 Waldenstrom Macroglobulinemia 3 Myelodysplastic Syndromes 3 Lymphoma, T-Cell, Cutaneous 3 Leukemia, Plasma Cell 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmacytoma 2 Peripheral Nervous System Diseases 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Leukemia, Hairy Cell 2 Leukemia 2 Infections 2 Hodgkin Disease 2

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡